吸入セボフルラン麻酔薬のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Inhalation Sevoflurane Anaesthetic Agent Market Insights and Forecast to 2027

• レポートコード：QY2112C03868 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は吸入セボフルラン麻酔薬の世界市場の現状について調査・分析し、2027年までの市場を予測しました。吸入セボフルラン麻酔薬の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ジェネリック医薬品、ブランド医薬品）、用途別市場規模（子供、成人）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・吸入セボフルラン麻酔薬の世界市場概要 ・メーカー別の競争状況、市場シェア ・吸入セボフルラン麻酔薬の種類別市場規模：ジェネリック医薬品、ブランド医薬品 ・吸入セボフルラン麻酔薬の用途別市場規模：子供、成人 ・北米の吸入セボフルラン麻酔薬市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの吸入セボフルラン麻酔薬市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの吸入セボフルラン麻酔薬市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の吸入セボフルラン麻酔薬市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの吸入セボフルラン麻酔薬市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：AbbVie、Baxter、Maruishi Pharmaceutical、Jiangsu Hengrui、Lunan Pharmaceutical ・吸入セボフルラン麻酔薬のバリューチェーン・販売チャネル分析 ・吸入セボフルラン麻酔薬の世界市場動向

Sevoflurane, also called fluoromethyl, is an ether inhalation anaesthetic agent used for the induction and maintenance of general anesthesia.

Market Analysis and Insights: Global Inhalation Sevoflurane Anaesthetic Agent Market
The global Inhalation Sevoflurane Anaesthetic Agent market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Inhalation Sevoflurane Anaesthetic Agent Scope and Segment
Inhalation Sevoflurane Anaesthetic Agent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation Sevoflurane Anaesthetic Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Generic Drug
Brand Drug

Segment by Application
Chidren
Adult

By Company
AbbVie
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan Pharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Inhalation Sevoflurane Anaesthetic Agent Product Introduction
1.2 Market by Type
1.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type
1.2.2 Generic Drug
1.2.3 Brand Drug
1.3 Market by Application
1.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application
1.3.2 Chidren
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Estimates and Forecasts 2016-2027
2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Estimates and Forecasts 2016-2027
2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Sales
2.4.1 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Sales (2016-2021)
2.4.2 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Sales (2022-2027)
2.5 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Revenue
2.5.1 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Revenue (2016-2021)
2.5.2 Global Top Inhalation Sevoflurane Anaesthetic Agent Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers
3.1.1 Global Top Inhalation Sevoflurane Anaesthetic Agent Manufacturers by Sales (2016-2021)
3.1.2 Global Top Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Inhalation Sevoflurane Anaesthetic Agent Sales in 2020
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers
3.2.1 Global Top Inhalation Sevoflurane Anaesthetic Agent Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2020
3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Historical Sales by Type (2016-2021)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Sales by Type (2022-2027)
4.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
4.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type
4.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Historical Revenue by Type (2016-2021)
4.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Revenue by Type (2022-2027)
4.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
4.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type
4.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2021)
4.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application
5.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Historical Sales by Application (2016-2021)
5.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Sales by Application (2022-2027)
5.1.3 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application
5.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Historical Revenue by Application (2016-2021)
5.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Forecasted Revenue by Application (2022-2027)
5.2.3 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application
5.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2016-2021)
5.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Application (2022-2027)

6 North America
6.1 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
6.1.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2027)
6.1.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2027)
6.2 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
6.2.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2027)
6.2.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2027)
6.3 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
6.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2027)
6.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
7.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2027)
7.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2027)
7.2 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
7.2.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2027)
7.2.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2027)
7.3 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
7.3.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2027)
7.3.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
8.1.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2027)
8.1.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2027)
8.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
8.2.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2027)
8.2.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2027)
8.3 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
8.3.1 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2027)
8.3.2 Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
9.1.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2027)
9.1.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2027)
9.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
9.2.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2027)
9.2.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2027)
9.3 Latin America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
9.3.1 Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2027)
9.3.2 Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Type
10.1.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2027)
10.1.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2027)
10.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Application
10.2.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2027)
10.2.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2027)
10.3 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
10.3.1 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2027)
10.3.2 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Overview
11.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Maruishi Pharmaceutical
11.3.1 Maruishi Pharmaceutical Corporation Information
11.3.2 Maruishi Pharmaceutical Overview
11.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Maruishi Pharmaceutical Recent Developments
11.4 Jiangsu Hengrui
11.4.1 Jiangsu Hengrui Corporation Information
11.4.2 Jiangsu Hengrui Overview
11.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Hengrui Recent Developments
11.5 Lunan Pharmaceutical
11.5.1 Lunan Pharmaceutical Corporation Information
11.5.2 Lunan Pharmaceutical Overview
11.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lunan Pharmaceutical Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Inhalation Sevoflurane Anaesthetic Agent Value Chain Analysis
12.2 Inhalation Sevoflurane Anaesthetic Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalation Sevoflurane Anaesthetic Agent Production Mode & Process
12.4 Inhalation Sevoflurane Anaesthetic Agent Sales and Marketing
12.4.1 Inhalation Sevoflurane Anaesthetic Agent Sales Channels
12.4.2 Inhalation Sevoflurane Anaesthetic Agent Distributors
12.5 Inhalation Sevoflurane Anaesthetic Agent Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalation Sevoflurane Anaesthetic Agent Industry Trends
13.2 Inhalation Sevoflurane Anaesthetic Agent Market Drivers
13.3 Inhalation Sevoflurane Anaesthetic Agent Market Challenges
13.4 Inhalation Sevoflurane Anaesthetic Agent Market Restraints

14 Key Findings in The Global Inhalation Sevoflurane Anaesthetic Agent Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Generic Drug
Table 3. Major Manufacturers of Brand Drug
Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021) & (K Units)
Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2021)
Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2022-2027) & (K Units)
Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2022-2027)
Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2016-2021)
Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2022-2027)
Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Manufacturers (2016-2021)
Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Manufacturers (2016-2021)
Table 18. Inhalation Sevoflurane Anaesthetic Agent Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Inhalation Sevoflurane Anaesthetic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Inhalation Sevoflurane Anaesthetic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalation Sevoflurane Anaesthetic Agent as of 2020)
Table 21. Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Inhalation Sevoflurane Anaesthetic Agent Product Offered
Table 23. Date of Manufacturers Enter into Inhalation Sevoflurane Anaesthetic Agent Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2016-2021)
Table 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Type (2022-2027)
Table 29. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2016-2021)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Type (2022-2027)
Table 33. Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2016-2021)
Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Sales Share by Application (2022-2027)
Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2016-2021)
Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Application (2022-2027)
Table 43. Inhalation Sevoflurane Anaesthetic Agent Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 46. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 47. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 50. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 51. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units)
Table 54. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2022-2027) & (K Units)
Table 55. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 58. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 59. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 62. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 63. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units)
Table 66. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2022-2027) & (K Units)
Table 67. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2022-2027) & (US$ Million)
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Major Businesses
Table 107. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AbbVie Recent Developments
Table 110. Baxter Corporation Information
Table 111. Baxter Description and Major Businesses
Table 112. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Baxter Recent Developments
Table 115. Maruishi Pharmaceutical Corporation Information
Table 116. Maruishi Pharmaceutical Description and Major Businesses
Table 117. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Maruishi Pharmaceutical Recent Developments
Table 120. Jiangsu Hengrui Corporation Information
Table 121. Jiangsu Hengrui Description and Major Businesses
Table 122. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Jiangsu Hengrui Recent Developments
Table 125. Lunan Pharmaceutical Corporation Information
Table 126. Lunan Pharmaceutical Description and Major Businesses
Table 127. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Lunan Pharmaceutical Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Inhalation Sevoflurane Anaesthetic Agent Distributors List
Table 133. Inhalation Sevoflurane Anaesthetic Agent Customers List
Table 134. Inhalation Sevoflurane Anaesthetic Agent Market Trends
Table 135. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
Table 136. Inhalation Sevoflurane Anaesthetic Agent Market Challenges
Table 137. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalation Sevoflurane Anaesthetic Agent Product Picture
Figure 3. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Type in 2020 & 2027
Figure 3. Generic Drug Product Picture
Figure 4. Brand Drug Product Picture
Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Market Share by Application in 2020 & 2027
Figure 6. Chidren
Figure 7. Adult
Figure 8. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered
Figure 9. Global Inhalation Sevoflurane Anaesthetic Agent Sales 2016-2027 (K Units)
Figure 10. Global Inhalation Sevoflurane Anaesthetic Agent Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Revenue 2016-2027 (US$ Million)
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2021)
Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2022-2027)
Figure 15. North America Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2016-2027) & (K Units)
Figure 16. North America Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2016-2027) & (US$ Million)
Figure 17. Europe Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2016-2027) & (K Units)
Figure 18. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2016-2027) & (K Units)
Figure 20. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2016-2027) & (K Units)
Figure 22. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales YoY (2016-2027) & (K Units)
Figure 24. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue YoY (2016-2027) & (US$ Million)
Figure 25. The Top 10 and Top 5 Players Market Share by Inhalation Sevoflurane Anaesthetic Agent Sales in 2020
Figure 26. The Top 10 and Top 5 Players Market Share by Inhalation Sevoflurane Anaesthetic Agent Revenue in 2020
Figure 27. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 28. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 29. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 31. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 32. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 33. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 34. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 35. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 36. North America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2016-2027)
Figure 37. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2016-2027)
Figure 38. United States Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 39. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 40. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 41. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 42. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 43. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 44. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2016-2027)
Figure 45. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2016-2027)
Figure 46. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 47. France Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 48. U.K. Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 49. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 50. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 51. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 52. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 53. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 54. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 55. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Share by Region (2016-2027)
Figure 56. Asia Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Region (2016-2027)
Figure 57. China Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 58. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 59. South Korea Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 60. India Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 61. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 62. China Taiwan Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 63. Indonesia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 64. Thailand Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 65. Malaysia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 66. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 67. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 68. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 69. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 70. Latin America Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2016-2027)
Figure 71. Latin America Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2016-2027)
Figure 72. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 73. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 74. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 75. Colombia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Share by Country (2016-2027)
Figure 82. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2027) & (US$ Million)
Figure 85. Inhalation Sevoflurane Anaesthetic Agent Value Chain
Figure 86. Inhalation Sevoflurane Anaesthetic Agent Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---